Stock listing

Cytomx Therapeutics, Inc.

Selected listing: CTMX · NASDAQ · USD · US

Cytomx Therapeutics, Inc. (NASDAQ:CTMX), Health Technology. Latest release Aug 27, 2026: CytomX Therapeutics Announces FDA Fast Track Designation…

CTMX:NASDAQUSDUSUpdated September 25, 2026

Ticker: NASDAQ:CTMX
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: NASDAQ
Currency: USD

About Cytomx Therapeutics, Inc.

Cytomx Therapeutics, Inc. is a public biotechnology company based in the United States, trading under the ticker CTMX. The company focuses on developing innovative cancer therapies using its proprietary Probody platform.

Latest news from Cytomx Therapeutics, Inc.

CytomX Therapeutics Announces FDA Fast Track Designation for Varsetatug masetecan (“Varseta-M”) for Relapsed/Refractory Metastatic Colorectal Cancer (R/R mCRC)

August 27, 2026

CytomX Therapeutics Announces Q2 2026 Financial Results and Provides Business Update

August 6, 2026

CytomX Therapeutics Appoints Alejandra Carvajal as Chief Legal Officer

August 3, 2026

CytomX Therapeutics to Report Second Quarter 2026 Financial Results on August 6, 2026

July 30, 2026

CytomX Therapeutics Announces Appointment of Charles Fuchs, M.D., M.P.H., to the Board of Directors

July 27, 2026

All Cytomx Therapeutics, Inc. news →

Events

Replays

CytomX Therapeutics, Inc. (CTMX) Q2 2026 Earnings Call
Thu, Aug 06, 2026 · 05:00 PM ET
Watch
CytomX Therapeutics, Inc. (CTMX) Q1 2026 Earnings Call
Thu, May 07, 2026 · 05:00 PM ET
Watch
CytomX Therapeutics, Inc. (CTMX) Q4 2025 Earnings Call
Mon, Mar 16, 2026 · 08:00 AM ET
Watch

Research Cytomx Therapeutics, Inc.

Cytomx Therapeutics, Inc. company profile

View the public company page for Cytomx Therapeutics, Inc. on 6ix.

Cytomx Therapeutics, Inc. news

Read company news and market updates connected to Cytomx Therapeutics, Inc..

Cytomx Therapeutics, Inc. investor events

Find investor webinars, events, and replay context for Cytomx Therapeutics, Inc..